AU Stock MarketDetailed Quotes

NSB Neuroscientific Biopharmaceuticals Ltd

Watchlist
  • 0.037
  • -0.003-7.50%
20min DelayMarket Closed Jul 5 14:37 AET
5.35MMarket Cap-5285P/E (Static)

Neuroscientific Biopharmaceuticals Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense
-41.69%6.12M
148.69%10.5M
43.59%4.22M
65.41%2.94M
1.78M
Selling and administrative expenses
-35.40%1.77M
73.58%2.73M
36.66%1.57M
96.96%1.15M
--584.95K
-General and administrative expense
-35.40%1.77M
73.58%2.73M
36.66%1.57M
96.96%1.15M
--584.95K
Research and development costs
-44.24%4.03M
225.53%7.22M
55.89%2.22M
94.78%1.42M
--730.42K
Depreciation amortization depletion
-10.88%57.85K
5.71%64.92K
8.38%61.41K
2.64%56.66K
--55.21K
-Depreciation and amortization
-10.88%57.85K
5.71%64.92K
8.38%61.41K
2.64%56.66K
--55.21K
Other operating expenses
-43.41%274.87K
31.35%485.73K
19.32%369.79K
-23.97%309.91K
--407.63K
Operating profit
41.69%-6.12M
-148.69%-10.5M
-43.59%-4.22M
-65.41%-2.94M
-1.78M
Net non-operating interest income (expenses)
50.18%102.8K
148.17%68.45K
-14.65%27.58K
-62.18%32.32K
85.44K
Non-operating interest income
57.09%107.53K
147.60%68.45K
-22.63%27.65K
-58.18%35.73K
--85.44K
Non-operating interest expense
--4.73K
----
-98.16%63
--3.42K
----
Other net income (expenses)
4.95M
2,411.67%1.02M
19.77%40.54K
33.85K
Other non-operating income (expenses)
--4.95M
----
2,411.67%1.02M
19.77%40.54K
--33.85K
Income before tax
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Income tax
0
0
0
0
0
Earnings from equity interest net of tax
Net income
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Net income continuous operations
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
---1.66M
Noncontrolling interests
Net income attributable to the company
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
89.76%-1.07M
-228.38%-10.44M
-10.78%-3.18M
-72.92%-2.87M
-1.66M
Diluted earnings per share
89.82%-0.0074
-227.48%-0.0727
39.51%-0.0222
-58.19%-0.0367
-0.0232
Basic earnings per share
89.82%-0.0074
-227.48%-0.0727
39.51%-0.0222
-58.19%-0.0367
-0.0232
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense -41.69%6.12M148.69%10.5M43.59%4.22M65.41%2.94M1.78M
Selling and administrative expenses -35.40%1.77M73.58%2.73M36.66%1.57M96.96%1.15M--584.95K
-General and administrative expense -35.40%1.77M73.58%2.73M36.66%1.57M96.96%1.15M--584.95K
Research and development costs -44.24%4.03M225.53%7.22M55.89%2.22M94.78%1.42M--730.42K
Depreciation amortization depletion -10.88%57.85K5.71%64.92K8.38%61.41K2.64%56.66K--55.21K
-Depreciation and amortization -10.88%57.85K5.71%64.92K8.38%61.41K2.64%56.66K--55.21K
Other operating expenses -43.41%274.87K31.35%485.73K19.32%369.79K-23.97%309.91K--407.63K
Operating profit 41.69%-6.12M-148.69%-10.5M-43.59%-4.22M-65.41%-2.94M-1.78M
Net non-operating interest income (expenses) 50.18%102.8K148.17%68.45K-14.65%27.58K-62.18%32.32K85.44K
Non-operating interest income 57.09%107.53K147.60%68.45K-22.63%27.65K-58.18%35.73K--85.44K
Non-operating interest expense --4.73K-----98.16%63--3.42K----
Other net income (expenses) 4.95M2,411.67%1.02M19.77%40.54K33.85K
Other non-operating income (expenses) --4.95M----2,411.67%1.02M19.77%40.54K--33.85K
Income before tax 89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Income tax 00000
Earnings from equity interest net of tax
Net income 89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Net income continuous operations 89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M---1.66M
Noncontrolling interests
Net income attributable to the company 89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 89.76%-1.07M-228.38%-10.44M-10.78%-3.18M-72.92%-2.87M-1.66M
Diluted earnings per share 89.82%-0.0074-227.48%-0.072739.51%-0.0222-58.19%-0.0367-0.0232
Basic earnings per share 89.82%-0.0074-227.48%-0.072739.51%-0.0222-58.19%-0.0367-0.0232
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg